Iq Eq Fund Management (Ireland) LTD Recursion Pharmaceuticals, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $831 Million
- Q4 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 200,470 shares of RXRX stock, worth $2.18 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
200,470
Previous 82,352
143.43%
Holding current value
$2.18 Million
Previous $542,000
150.0%
% of portfolio
0.16%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
338Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$370 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$352 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$270 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$188 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$159 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.96B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...